Tìm kiếm "Can thiệp y tế"

Nếu chưa tìm được tài liệu, vui lòng

Thử tìm trên TàiLiệuTươi.com

Tìm kiếm tài liệu, văn bản Can thiệp y tế

Chronic hypoxia Pediatric medulloblastoma F-box protein family Basaloid squamous cell carcinoma Forced running wheels Inadequate oral intake Aberrantly expressed microRNAs Human papilloma virus antigen E7 DR5 dependent apoptosis Oncomine database Prior cancer Solid tumor progression First-line Cell junctions Radiation-induced intestinal fibrosis Tumor biomarker Endoscopic feature Aspartic transaminase Molecular risk scores Intracranial aneurysms formation Human epidermal receptor 2 Frail patients Fibroblast growth factor 2 Murine mammary tumor TTF-1 expression Hepatic injury EP4 receptor Sorting nexin 27 Interfraction motion Non-randomized phase II Perfusion CT Chronic comorbid pathologies Pancreatic neoplasm Normal neural tissue plasticity Cell division cycle associated 2 Cancer screening uptake Non-Hodgkin Endocrine treatment Aberrant methylation Stage IV lung adenocarcinoma Mouse embryogenesis Mutation profiling VEGF receptors Nonruptured cerebral aneurysm Hypothesized TNM staging system Gene expression measurement Multiple cancer types Squamous cell carcinomas Familial ovarian cancer Cancer-related stigma attracts Distant omental metastases NTRK2-encoded protein Cauda equine EGFR-sensitizing mutations Stem-like cells Lung cancer model Topoisomerase I gene Adaptive design TNM staging system Tumor evolution EGFR exon 20 insertion mutations Cranial-caudal Favoring endocrine treatment Estradiol metabolism Bladder urothelial carcinoma Cancer stigma Branched chain amino acid transaminase 1 Polysome profiling Prenylated Rab acceptor 1 domain family Nanos sequences Bayesian adaptive Non-complete response NTRK1 fusion Mutated BRCA1/2 genes Heterogeneous behavior YAP inhibits growth Western blot analysis Mastermind-like transcriptional coactivator 3 DNA methyltransferase 1 Maximal tolerated dose Nanos paralogs LIHC transcriptomics Antibody therapeutics Several malignant tumors Despite Neo-Bioscore Overall surviva Phase angle Hep-2 laryngeal cancer cells Co-immunoprecipitation analysis Transcriptional network Serum chitinase activity prognosticates metastasis Remarkably universal Valproic acid-induced amphiregulin Preclinical model Stage-specific biomarkers Nodal status Model-based design Penile squamous cell carcinoma Lateral lymph node metastasis Temozolomide treatment

Tài liệu, văn bản bạn tìm kiếm

Ganglionic PSMA expression, Tumor supressor gene, Pig model, Rule-based design, Human glioma cells, Pairwise contrasts, DNA aneuploidy, Kinase-impaired, Inter-alpha-trypsin inhibitor heavy chain 4, Ependymal tumor, PI3 kinase, Neoplasm metastasis, Significance analysis, Individual cancer, SDS gel electrophoresis, Benchmark treatment, Clinical mutational profiling, Meta-analysis aims, Invasive front, Linear modelling, Molecular features facilitate tumor grading, BRAF mutations, Uterine sarcoma, Multifactorial disease, Microvascular proliferation, Epithelialmesenchymal transition, APC hypomorph, Oxaliplatin regimen, Argonaute 2, Total hysterectomy, Sterol-regulatory element binding protein 1, Platelet-to-lymphocyte ratios, Accumulates numerous genetic, Tyrosine kinases induce tyrosine phosphorylation, Distant tumor control, Cyclin-dependent kinase 5, European surgeons, Intracellular cholesterol sensor, Sex-specific diagnosis, Tumor migratory, Integrative therapies, Uterine carcinosarcoma, Ovarian fertility, Tissue microarrays, Trophoblast cells, Leptomeningeal metastasis, Promising biomarker, Molecular tumor profiling, Identify biomarkers, Bone and soft tissue sarcomas, Frequently aggressive clinical nature, Single-cell RNA-seq, Granulosa cell tumour, Poor recurrence-free survival, Patient attitudes, Mutation carriers, Human embryonic stem cells, Gemcitabine and docetaxel, Cytotoxic chemotherapy, Salivary adenoid cystic carcinoma, Metastatic solid cancer, Multivariate regression model, Reference gene expression profiles, Clinical tumour, Chinese medicinal plant, Nuclear receptor subfamily, Phase 2 study, Exhausted therapeutic, Cancer Epigenomics, Tumor dormancy, SET domain containing 5, Erythroleukemic cell lines, ERK signaling, Interstitial pneumonitis, Healing environments, Emerging evidence, Radiation recall pneumonitis, Breakpoint cluster region, Healthcare access, Human chorionic gonadotropin beta subunit, Thoracic radiotherapy, Particle radiotherapy, Human L1TD1 gene, Early stage breast cancer, Parotid squamous cell carcinoma, Healthcare burden, Systemic inflammation score, Non-seminoma, Tongue cancer resistance-associated protein, Primary tumor resection, Germ cell tumour, Bladder leiomyosarcoma, Age at onset, Leucine zipper transcription factor-like 1, Ca2+ sensor, Brest cancer stem cell, Clinicopathological spectrum, OS predicting, Orbital malignancies, Squamous cell carcinoma of the tongue, NF-κB phosphorylation, Antisense transcript mediates, Stearoyl-CoA desaturase 1, Leicester cough questionnaire, Atypical protein kinase C, AP2 transcription factor, Better prognosis, Trophoblastic neoplasia, Pure seminoma, Nomogram-predicted probability score, DNA-repair genes, Osteoclast-like multinucleated giant cells, Relapse risk score, Oncogenic microRNA, Eye-sparing surgery, Prognosis analysis, Low-dose decitabine, Cabazitaxel plus prednisone, Solitary Plasmacytoma, Sphere-forming assay, Circ-Foxo3, Emergency chemotherapy, Protein kinase C iota, Semi-quantitative score, Unilateral thyroidectomy, Competing endogenous RNAs network, Soft clustering, Gingiva squamous cell carcinoma, Valuable biomarker, Hormonal therapy treatment, Proton radiotherapy, Frequent mesenchymal neoplasm, Anti-sense pair, Intermediate-dose cytarabine, PALETTE subgroup analysis, Therapeutic recommendations, Hemipelvic endoprosthesis, Pelvic tumor, Nanoliposomal-irinotecan, Adoptive T-cell immunotherapy, Limb salvage, Adrenal tumor, Ankyrin-repeat, N2 lymph node metastasis, Antigen loss, Brain radiotherapy, Pancreatic metastases, Malignant pelvic tumors, Extra-adrenal cancer, SH3-domain, Sequential CAR-T cell therapy, Uncommon mutations, Hydatidiform mole, Synchronous extra-adrenal malignancy, Ameliorate hypopharyngeal cancer, Basal cell, Oxalate nephropathy, Bone cancer, Retrieved imaging diagnosis, Heterogeneous nuclear ribonucleoprotein K, Smac mimetic, Head and neck carcinoma, Paclitaxel-induced, Invasiveness pathways, Microtubuleassociated protein 1B light chain, Inhaled drugs, IAP antagonist, Dual-targeted therapy, Non-degraded RNA, ALI cultures, Mouse cancer model, Fibrin-associated, Anal squamous cell carcinoma, HER3 overexpression, Manual lymphatic drainage, Following definitive chemoradiation, Cardiac myxoma, Prior malignancy, Cancer stem-like tumorsphere, Bowel dysfunction, Determination of resectability, Receptor tyrosine kinases, Accelerated bone loss, Borderline resectable, Activation and function, CRC progression, Prospective randomized multicenter trial, Glioma cell growth, Stroma cells, Interleukin-6 mediates resistance, Palliative gastrectomy, PI3Kpathway–targeted therapy, Validate prognostic nomograms, Lymphoma patients, Metastatic gastric adenocarcinoma treated, Multiband mucosectomy, Vaginal adenosis, Ovarian cancer metastasis, High-occurrence area, Blood-based microRNAs, Vaginal clear cell carcinoma, Inhibitory short peptide, Atypical teratoid, Osteoclast-like giant cells, Endoscopic submucosal excavation, Phase 1 clinical trials, Circ-SMARCA5 suppresses progression, Atypical glandular cells, ABI1 tri-complex, Rhabdoid tumor, Multifocal fluorodeoxyglucose, Bispecific antibody, Comprehensive molecular, Intraneural glomus tumor, Submucosal tumours, Malignant effusion, Sites of metastasis, Distant failure, Lysopho-sphatic acid, Sex disparity, Mast cell, Highly malignant brain tumors, Pseudomyogenic hemangioendothelioma, T-cell therapy, Hepatic arterial infusion chemotherapy, Dose limiting toxicity, Asian melanoma, Highly conformal manner, Fatty natural killer cells, Digital nerve, Leucine zipper-EF-hand-containing transmembrane protein 1, Chemotherapy treatment options, Clear cell sarcoma of the kidney, Standardized uptake value, Rapid kidney clearance, Tubal sterilization, SMARCB1 gene, Protein tyrosine phosphatase non-receptor 12, Proteomic profiling, KIT mutational statuses, Cancer stemness, Perioperative immunosuppression, Non-sex-specific cancers, Tumour recurrence, TM6SF2 gene polymorphism, Carbon ion radiation therapy, BCL-6 corepressor, Multi-center randomized phase II, Lymphomatous polyposis, Anti-tumor antigen scFv fragments, Tubal ligation, Natural killer, Therapeutic strategy, Quantitative Gleason grade, Pancreatic head and body-tail cancers, Preoperative 5-FU-based chemoradiation, Fibroblast growth factor receptor 3, Immune checkpoint blockade, Children following Wilms’ tumor, NK cell scavenger receptor, Complement system-related pathways, Matrine derivate, Eukaryotic translation initiation factors 3 subunit b, Marginal zone B-cell lymphoma, Melanoma remains unclear, Desmoplastic small round cell tumor, HER-positive breast cancer, Lymphocyte-sparing, Tumor killing, Tumor cell interaction, Trauma- and stressor-related disorders, Potential implementation, Frequent pediatric tumor, AJCC staging system, Distinguishing malignant, Hereditary cancer syndromes, Translocation renal cell carcinoma, Testis-expressed protein 9, Unique macroscopic, FGFR3 gene decreased, Trastuzumab monotherapy, Immune molecular mechanisms, Human carcinoma, Preoperative inflammation-based prognostic scores, Simultaneous primary cancer occurrence, CA19–9 decrease during treatment, Active treatment plan, Conventionally fractionated, Mitotic kinases, Anti-apoptotic protein, Multimodal management, Degree of Spread, Fusion gene, Locally advanced squamous cell carcinoma, Sophora genus, Long-term responders, Neuropeptide signaling pathway, BRCA1 associated-protein 1, Local consolidative therapy, Natural killer-enriched lymphocytes, Retrospective studiess, Pulmonary adenocarcinoma, Tumor cell survival, Colorectal advanced neoplasia, IDH mutations, High-dose cisplatin, Renal cell carcinomas, Pathological findings confirmed, Non-squamous histology, First-line chemotherapy regimen, Controlling nutritional status, Tumor predisposition syndrome, Rhabdomyosarcomatous dedifferentiation, BLM helicase, Clinicopathologic association, Antibody-dependent cell-mediated cytotoxicity, Blood inflammatory markers, Alimentary mucositis, TFE3 gene fusion, Diagnosis relies predominantly, Bacteroides fragilis, EGFR amplification, Comorbidity index, High-dose intravenous methotrexat, Mucinous ovarian cancer, Oncoplastic surgery, Screening colonoscopy, Ziv-aflibercept, Patient-derived organoids, Fluorescence polarization, Human transcriptome Array 2.0, Transcription-coupled, MGMT promoter methylation, Mapping patterns, Clear-cell ovarian cancer, Biliary rhabdomyosarcoma, RNA world, Sentinel lymph node, Rectal neoplasm, MEG3 non-coding RNA, Esophageal cancer surgery, Bisbenzylisoquinoline alkaloids tetrandrine, Inducing epithelial cell, Chronic-phase chronic myeloid leukemia, Chemotherapy reagents, Immuno-PET, Boost definition, Recurrent nodes, CWS Studiengruppe, Paediatric tumour, Advanced solid tumors, Surgical procedures performed, Years of potential productive life lost, Ciona intestinalis, Triple negative breast cancer cell lines, Ovarian cancer symptoms, Complete pathological response, Indocyanine green fluorescence, Breast conserving therapy, Biliary tumor, Productivity costs, Chemotherapy refractory metastatic colorectal cancer, Cell adhesion molecule NCAM, Ovarian cancer signs, Muscle mass depletion, Metastasis of bone, Tumor entity, Upper abdominal region, Human capital approach, Protein-RNA interactions, In silico prescription, Cetuximab therapy, Ovarian cancer tests, Metastasis of sigmoid colon, Subungual melanoma, Molecular basis of disease, Histologic subtypes, Non-amputative digit preservation surgery, Immunohistochemical methods, Signet-ring cell carcinoma, Local dissemination, Single arm confirmatory trial, Adenocarcinoma with mixed subtypes, Osteosarcoma observed, Non randomized trial, Solid cancer, Elderly patient, Ex vivo culture, Despite undergoing chemotherapy, Emetogenic chemotherapy, β-arrestin-2, Cell proliferation rate measurement, Radiation-induced nausea and vomiting, Chemotherapy-induced nausea, Predictive test system, Enzyme gamma-glutamyltransferase, Cell transfection, Antiemetic prophylaxis, Serum gamma-glutamyltransferase, DNA damaged binding protein 2

Đánh giá
Can thiệp y tế - 4 sao (17 lượt)